International Research Institute Servier (IRIS), Suresnes (France)
Follow
Contributor content
Presentation
Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects
